APA (7th ed.) Citation

Mousavi Khorshidi, M. S., Seeleuthner, Y., Chavoshzadeh, Z., Behfar, M., Hamidieh, A. A., Alimadadi, H., . . . Casanova, J. (2023). Clinical, Immunological, and Genetic Findings in Iranian Patients with MHC-II Deficiency: Confirmation of c.162delG RFXANK Founder Mutation in the Iranian Population. Journal of Clinical Immunology, 43(8), 1941. https://doi.org/10.1007/s10875-023-01562-z

Chicago Style (17th ed.) Citation

Mousavi Khorshidi, Mohadese Sadat, et al. "Clinical, Immunological, and Genetic Findings in Iranian Patients with MHC-II Deficiency: Confirmation of C.162delG RFXANK Founder Mutation in the Iranian Population." Journal of Clinical Immunology 43, no. 8 (2023): 1941. https://doi.org/10.1007/s10875-023-01562-z.

MLA (9th ed.) Citation

Mousavi Khorshidi, Mohadese Sadat, et al. "Clinical, Immunological, and Genetic Findings in Iranian Patients with MHC-II Deficiency: Confirmation of C.162delG RFXANK Founder Mutation in the Iranian Population." Journal of Clinical Immunology, vol. 43, no. 8, 2023, p. 1941, https://doi.org/10.1007/s10875-023-01562-z.